idoxuridine has been researched along with clevudine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, JJ; Hirota, K; Lopez, C; Reichman, U; Watanabe, KA | 1 |
| Biggadike, K; Borthwick, AD; Coates, JA; Evans, DN; Exall, AM; Kirk, BE; Knight, DJ; Roberts, SM; Youds, P | 1 |
| De Clercq, E; Griengl, H; Rosenwirth, B; Schwarz, W; Streicher, W; Wanek, E | 1 |
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
4 other study(ies) available for idoxuridine and clevudine
| Article | Year |
|---|---|
Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.
Topics: Antiviral Agents; Arabinonucleosides; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Virus Replication | 1979 |
Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-beta-D-arabinofu
Topics: Animals; Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Crystallography; Influenza A virus; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Pyrimidine Nucleosides; Simplexvirus; Vero Cells; Virus Replication | 1990 |
2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
Topics: Antiviral Agents; Bromodeoxyuridine; Deoxyuridine; Floxuridine; Simplexvirus; Structure-Activity Relationship | 1987 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |